Skip to main content

Peer Review reports

From: AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial

Original Submission
27 May 2020 Submitted Original manuscript
28 May 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
30 May 2020 Editorially accepted
19 Jun 2020 Article published 10.1186/s13063-020-04473-1

You can find further information about peer review here.

Back to article page